Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Dirigidas en Enfermedades Reumáticas

Biobadaser Fase III

Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration. Annals of the rheumatic diseases. 2019;78(11):1536-44.

28/02/2022

Ørnbjerg LM, Brahe CH, Askling J, Ciurea A, Mann H, Onen F, et al.

Epub 2019/08/23. doi: 10.1136/annrheumdis-2019-215427. PubMed PMID: 31431486.